How Telehealth Hair Loss Consultations Work: The Process Explained

"Fill out a form, get a prescription" is the common shorthand for telehealth hair loss care — but that undersells what's actually supposed to happen behind the scenes, and glosses over real differences between providers. Here's what a legitimate telehealth hair loss consultation actually involves, what the law does and doesn't require, and what's worth checking before you sign up with any provider.

The intake process

A telehealth hair loss consultation is supposed to gather largely the same clinical information an in-person visit would: the pattern and duration of your hair loss, how fast it's progressing, family history, current medications, medical conditions, any recent illness or major stress, scalp symptoms, prior treatments tried, and — where relevant — pregnancy plans and reproductive status.

Two basic models exist:

• Asynchronous ("store-and-forward"): you submit history and photos, a clinician reviews it later. No live appointment required.
• Synchronous: a live video (or occasionally phone) visit with a clinician in real time.

Many platforms use asynchronous review for straightforward cases, since a live video call isn't the only path to an adequate evaluation — though whether that format is allowed still depends on state rules.^[1]

Photo requirements matter more than people expect

For hair loss specifically, useful photo documentation generally needs multiple angles, not one selfie:

• Frontal hairline
• Temples
• Mid-scalp
• Crown/vertex
• Part line
• Back or sides, for comparison

This matters because image quality genuinely affects remote diagnostic accuracy. In a general teledermatology study of skin-lesion image acquisition — not a hair-loss study — diagnosis match was 79% with unassisted patient photos versus 87% with resident-taken photos.^[7]That gap is illustrative of why lighting, focus, distance, and multiple angles matter if you're submitting photos remotely for any dermatologic condition, including pattern hair loss.

Evidence that asynchronous review can work for alopecia — with caveats: a 2025 UPMC e-Derm/e-consult study of 321 non-scarring alopecia cases reached a definitive remote diagnosis in 91.3% of cases; the remaining 8.7% needed in-person evaluation, usually for biopsy or additional diagnostic clarity.^[3] That case mix was alopecia areata–heavy (about 59.5% AA vs. 26.5% androgenetic alopecia), and the workflow used referring-provider photos and history — not a direct-to-consumer selfie questionnaire. It supports remote diagnosis for many non-scarring alopecia presentations in that setting, while still showing roughly 1 in 11 cases needed escalation — which is exactly why an in-person referral option matters.

Is a live video visit actually required?

No — not universally, and not by federal law. Finasteride is prescription-only but not a federally controlled substance; topical minoxidil is over-the-counter; oral minoxidil is prescription-only and off-label.^[6]The Federation of State Medical Boards' model policy doesn't treat video as inherently required — it expects the same standard of care as in-person care and permits telemedicine when the clinician can gather enough clinical information for diagnosis and treatment, however that information is collected.^[1]

"No video required" doesn't mean "no real evaluation required."The same clinical standard is supposed to apply regardless of delivery method. A platform can't justify a thin history, poor photos, or ignoring red flags just because its model is questionnaire-based.^[1]

Asynchronous review is most defensible when:

• The pattern is typical, non-scarring androgenetic alopecia
• Photos are clear and cover multiple angles
• History is consistent with a straightforward diagnosis
• State law allows an appropriate asynchronous clinical evaluation (not a static questionnaire alone)

It becomes less adequate when:

• Loss is sudden, patchy, painful, inflamed, or shows signs of scarring
• Photos are poor quality
• The diagnosis is genuinely uncertain
• A physical exam, dermoscopy, labs, or biopsy could change the treatment plan
• State rules treat pure store-and-forward evaluation as inappropriate

State rules diverge here. Maryland, for example, allows a synchronous or asynchronous clinical evaluation when appropriate for the patient and condition, but may not treat or prescribe based solely on a static online questionnaire.^[2] Rhode Island is stricter: under 216-RICR-40-05-1, prescribing based solely on an online questionnaire without an appropriate evaluation is unprofessional conduct, and asynchronous evaluation without a contemporaneous real-time, interactive exchange is not appropriate.^[4]That is not the same as "async is fine as long as the form feels thorough" — RI expects real-time interaction, not pure store-and-forward alone.

Who's actually allowed to prescribe?

• Licensed MDs/DOscan prescribe finasteride or oral minoxidil within ordinary practice, as long as they're authorized to practice in the state where you are physically located
• Nurse practitioners can prescribe where their state license and prescriptive authority allow — some states permit full independent practice, others require physician collaboration or supervision
• Physician assistants can prescribe when state law and their supervision/collaboration arrangement authorize it

There's no hair-loss-specific federal license — authority comes entirely from state medical, nursing, or PA practice law, not from the telehealth company itself.

The state that governs the visit is the state you're physically in at the time — not your permanent address, and not wherever the company is headquartered. A clinician licensed only in one state generally can't treat you if you're located in a different state, though interstate licensing compacts can streamline this in some cases.^[1]

Do labs matter here?

For finasteride: routine baseline bloodwork isn't required by FDA labeling for a generally healthy man starting treatment — diagnosis of typical pattern hair loss is usually clinical.^[6]Labs become more relevant if the history suggests something else (thyroid disease, iron deficiency, telogen effluvium). One thing worth knowing regardless of your bloodwork: finasteride lowers PSA — in one trial of men ages 40–60, median PSA dropped about 40% (ages 40–49) to 50% (ages 50–60) after 48 weeks; the Propecia label reports a mean drop from 0.7 to 0.5 ng/mL at Month 12 in men 18–41.^[5][6]There is no single universal U.S. age cut for baseline PSA before finasteride: the European S1 AGA guideline historically recommended PSA before treatment for men over 45, while the Spanish AEDV 2024 consensus recommends PSA for men over 50 (over 40 if Black). Any clinician ordering or reading a future PSA test needs to know you're on finasteride — otherwise, the result could be interpreted incorrectly.

For topical minoxidil: no baseline labs typically needed — screening instead focuses on cardiovascular symptoms, sudden or unexplained hair loss, and scalp disease.

For oral minoxidil:a more cardiovascular-focused evaluation is warranted, since it's a systemic blood pressure medication used off-label for hair loss. See our oral minoxidil safety guide for what that screening should actually include.

Why this varies so much by state

No state specifically bans telehealth prescribing of finasteride by name — but general rules around licensure, how the clinician-patient relationship gets established, and asynchronous care requirements vary widely:

• Some states expressly allow async clinical evaluation when appropriate (e.g., Maryland), while still barring prescribing on a static questionnaire alone^[2]
• Others go further: Rhode Island treats questionnaire-only prescribing without appropriate evaluation as unprofessional conduct and states that asynchronous evaluation without contemporaneous real-time interactive exchange is not appropriate;^[4] Kansas is often grouped with states that reject bare questionnaire-only prescribing
• NP and PA prescribing authority varies independently of telehealth rules — meaning the same platform might use physicians in one state and supervised NPs in another

This is exactly why "state law" isn't a throwaway line — it's the actual mechanism determining whether a given platform's process meets a real evaluation standard where you live.

The typical process, step by step

1. Registration and identity/location verification
2. Consent to telehealth + medical history intake
3. Scalp photo upload (multiple angles)
4. Clinician review (someone licensed in your state)
5. Follow-up questions, a live visit, lab order, or an in-person referral if the case warrants it
6. Treatment decision and prescription
7. Pharmacy dispensing and shipping
8. Scheduled or patient-initiated follow-up

A note on timeline claims:there's no independent, authoritative study establishing a "typical" turnaround time from intake to medication delivery — this varies by clinical review needs, state requirements, pharmacy processing, and shipping. Be skeptical of specific speed promises ("prescription in 24 hours!") as marketing rather than a clinical or regulatory standard.

What to actually check before choosing a provider

A credible process should include more than an automated eligibility form. Worth confirming before you commit:

• Is your location and identity actually verified?
• Does the intake gather real history — not just a handful of eligibility questions?
• Are photo requirements substantive (multiple angles), not a single upload?
• Is the prescriber's name, credential, and state license identifiable?
• Is there a clear path to in-person referral if your case doesn't fit the typical pattern?
• Is follow-up access built in, not just a one-time transaction?

This lines up closely with what we evaluate on our Hair Loss comparison hub — consultation model, credential transparency, and cancellation/support access are core parts of how we score every provider, precisely because "video vs. no video" isn't the meaningful question. Whether a real evaluation happens is.

FAQ

Comparing providers

If you're trying to figure out which telehealth hair loss providers actually run a thorough process versus a bare-minimum one, our Hair Loss Provider Match Quiz and comparison hub evaluate exactly these factors — consultation model, credential disclosure, and support access — so you don't have to dig through every provider's terms of service yourself.

*This article is for informational purposes only and is not medical advice or legal advice. RENVA is not a healthcare provider. Telehealth regulations vary by state and change over time; confirm current requirements with the specific provider and your state's medical board if you have questions about a particular platform's process.*